Close
ACHEMA MIDDLE EAST 2026

WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa

WuXi Biologics , a global company with leading open-access biologics technology platforms, and AB2 Bio Ltd., a Swiss advanced clinical-stage biotech company developing innovative...

Affibody Announces Initiation of Confirmatory Phase 2 Trial of ABY-035 in Psoriatic Arthritis Patients

Affibody AB, a clinical stage biopharmaceutical company, announced the initiation of its 52-week trial investigating the novel bispecific IL-17A inhibitor ABY-035 in patients with...

TraceLink Announces New Serialized Product Intelligence Solution

TraceLink, Inc., the leading digital platform company for the life science supply chain, introduced Serialized Product Intelligenceā„¢, a new cloud application that uses serialization...

Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership with Catalent

Taysha Gene Therapies Inc., a patient-centric gene therapy company focused on developing and commercializing adeno-associated virus (AAV)-based gene therapies for the treatment of monogenic...

Thermo Fisher Scientific signs Partnership Agreement with the new Terasaki Innovation Center for Transplant Diagnostic Research

Thermo Fisher Scientific today announced it signed a partnership agreement with the newly formed Terasaki Innovation Center (TIC) to facilitate discovery and development of...

Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

Thermo Fisher Scientific, the world leader in serving science, and the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University, have entered into a collaborative...

Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine

Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...